1,2-Bis[(2R,5R)-2,5-diethylphospholano]benzene(1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate

• Catalog No.: 698393
• CAS Number: 136705-77-6
• M. F.: C31H48F3O3P2RhS
• M. W.: 722.6242516

SYNONYMS

• Title: 1,2-双[(2R,5R)-2,5-二乙基膦烷基]苯(1,5-环辛二烯)三氟甲磺酸铑(I)
• IUPAC name: λ^1-rhodium(1+) ion (2R,5R)-1-{2-[(2R,5R)-2,5-diethylphospholan-1-yl]phenyl}-2,5-diethylphospholane cycloocta-1,5-diene trifluoromethanesulfonate
• IUPAC Traditional name: λ^1-rhodium(1+) ion (2R,5R)-1-{2-[(2R,5R)-2,5-diethylphospholan-1-yl]phenyl}-2,5-diethylphospholane 1,5-cyclooctadiene triflate
• Synonyms: (R,R)-Et-DUPHOS-Rh

DATABASE IDS

• MDL Number: MFCD00269860
• CAS Number: 136705-77-6

PROPERTIES

• Empirical Formula (Hill Notation): C31H48F3O3P2RhS
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36/37
• German water hazard class: 3

DETAILS

Description (English)

Packaging
50, 250 mg in glass bottle
Legal Information
Sold in collaboration with Kanata Chemical Technologies Inc. for research purposes only. These compounds were made and sold under license from E.I. du Pont de Nemours and Company, which license does not include the right to use the compounds in producing products for sale in the pharmaceutical field.
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Stereoselective synthesis of δ-amino acid derivatives via asymmetric hydrogenation of acetylaminopentenoic acid derivatives1
• Stereoselective synthesis of manzacidins A and C via stereoselective hydrogenation2
• Stereoselective synthesis of tetracyclic core of manzamine A via Rh-catalyzed asymmetric hydrogenation, diastereoselective Diels-Alder reaction, Eschenmoser-Tanabe fragmentation, Chang′s amide formation, and Hofmann rearrangement3
• Asymmetric preparation of chiral Cbz-aminodifluorobutyric acid Me ester and its analogs4
• Biphasic catalytic hydrogenations in ionic liquids with addition of water as a second solvent5
• Preparation of cyclobutane-containing amino acids via asymmetric hydrogenations of cyclobutyl enamides6
• Asymmetric preparation of both enantiomers of (dimethoxycoumaryl)alanine as suitable fluorescent peptide labels7

Description (简体中文)

包装
50, 250 mg in glass bottle
Legal Information
与 Kanata Chemical Technologies Inc. 联合销售，仅供研究使用。这些化合物由 E.I. du Pont de Nemours and Company 授权制造和销售，此许可不包括利用这些化合物制备在制药领域销售的产品的权利。
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Stereoselective synthesis of δ-amino acid derivatives via asymmetric hydrogenation of acetylaminopentenoic acid derivatives1
• Stereoselective synthesis of manzacidins A and C via stereoselective hydrogenation2
• Stereoselective synthesis of tetracyclic core of manzamine A via Rh-catalyzed asymmetric hydrogenation, diastereoselective Diels-Alder reaction, Eschenmoser-Tanabe fragmentation, Chang′s amide formation, and Hofmann rearrangement3
• Asymmetric preparation of chiral Cbz-aminodifluorobutyric acid Me ester and its analogs4
• Biphasic catalytic hydrogenations in ionic liquids with addition of water as a second solvent5
• Preparation of cyclobutane-containing amino acids via asymmetric hydrogenations of cyclobutyl enamides6
• Asymmetric preparation of both enantiomers of (dimethoxycoumaryl)alanine as suitable fluorescent peptide labels7